Skip to content
Screener

Arrowhead Research ARWR Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Beam Therapeutics logo
Beam TherapeuticsBEAM
$93.89M
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$49.45M
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The source filing: Arrowhead Research’s 10-K, filed November 25, 2025.

Filed
Nov 25, 2025
Fiscal year
FY2025
Accession
0000879407-25-000029
Line itemYear Ended September 30, 2025Year Ended September 30, 2024Year Ended September 30, 2023
Proceeds from the issuance of common stock241,388
Proceeds from credit facility392,000
Repayments of credit facility(201,625)
Proceeds from Visirna credit agreement10,260
Net cash provided by financing activities74,006870,520253,053
Net increase (decrease) in cash, cash equivalents and restricted cash124,264(12,403)3,008
Effect of exchange rate on cash, cash equivalents and restricted cash(401)4,197(122)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:

ITEM 16.FORM 10-K SUMMARY

FAQ

What is Arrowhead Research's debt issuance proceeds?
Arrowhead Research (ARWR) reported debt issuance proceeds of $3.16M in Q3 2025.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Ask your AI about Arrowhead Research's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude